Dilantin Maker Ordered to Produce Foreign Labels, Patient Guides

MACON, Ga. - A Georgia federal judge has ordered Pharmacia Corp. to produce foreign labels and patient guides in a case in which a plaintiff claims that its anti-seizure drug Dilantin caused her to develop Stevens-Johnson Syndrome. Hardy v. Pharmacia Corp., No. 09-119 (M.D. Ga.).

On May 27, Judge Clay D. Land of the U.S. District Court for the Middle District of Georgia ruled that the information could lead the plaintiff to discover admissible evidence as to whether the drug maker's warnings were adequate.

Carmen Hardy alleges that her ingestion of Dilantin in 2007 caused her to develop Stevens-Johnson Syndrome, …